Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Financial toxicity in the cancer patient journey

The 8th Kenya International Cancer Conference KICC

21 - 23 Nov 2024

Published: 20 Jan 2025

Views: 58

Rating:

Save

Dr Matiko Riro - Health Financing, Ministry of Health, Nirobi, Kenya

Financial toxicity creates a burden, especially in Kenya, where many incur debt for care. Universal Health Coverage aims to prevent poverty from healthcare costs. Limited insurance leads to high out-of-pocket expenses, increasing mortality risk and treatment abandonment. Strategies like early diagnosis and expanded insurance coverage are vital to mitigate these issues.

Related Videos

Addressing cancer control challenges in Africa

Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria

Addressing cancer control challenges in Africa ( Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India

Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024 ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )

The long-standing partnership between Tata Medical Center, Kolkata and ecancer Global Foundation

Dr Pattatheyil Arun - Tata Medical Centre, Kolkata, India

The long-standing partnership between Tata Medical Center, Kolkata and ecancer Global Foundation ( Dr Pattatheyil Arun - Tata Medical Centre, Kolkata, India )

Addressing Breast Cancer Disparities in Africa

Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland

Addressing Breast Cancer Disparities in Africa ( Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer